295 related articles for article (PubMed ID: 10347628)
41. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
[TBL] [Abstract][Full Text] [Related]
42. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
Ariyoshi Y; Ogawa M
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
[TBL] [Abstract][Full Text] [Related]
43. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
[TBL] [Abstract][Full Text] [Related]
44. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
[TBL] [Abstract][Full Text] [Related]
45. Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantation.
Bojko P; Akca A; Seeber S
Bone Marrow Transplant; 2003 Jun; 31(11):995-1000. PubMed ID: 12774050
[TBL] [Abstract][Full Text] [Related]
46. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Donato ML; Gershenson DM; Wharton JT; Ippoliti CM; Aleman AS; Bodurka-Bevers D; Bevers MW; Burke TW; Levenback CF; Wolf JK; Freedman RS; Bast RC; Gajewski JL; Champlin RE
Gynecol Oncol; 2001 Sep; 82(3):420-6. PubMed ID: 11520135
[TBL] [Abstract][Full Text] [Related]
47. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
48. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of transplantation material based on immunophenotype and in vitro clonogenic assays of hematopoietic stem and progenitor cells].
Balana-Nowak A; Zdziłowska E; Szostek M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():28-33. PubMed ID: 10494179
[TBL] [Abstract][Full Text] [Related]
50. High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern Switzerland.
Regazzoni S; Marini G; Grob A; Pedrazzini A; Goldhirsch A; Castelli D; Cavalli F; Ghielmini M
Bone Marrow Transplant; 1997 Jan; 19(1):3-7. PubMed ID: 9012924
[TBL] [Abstract][Full Text] [Related]
51. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
[TBL] [Abstract][Full Text] [Related]
52. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
[TBL] [Abstract][Full Text] [Related]
53. Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Svane IM; Homburg KM; Kamby C; Nielsen DL; Roer O; Sliffsgaard D; Johnsen HE; Hansen SW
Acta Oncol; 2002; 41(7-8):675-83. PubMed ID: 14651213
[TBL] [Abstract][Full Text] [Related]
54. Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor.
Shigemura K; Tanaka K; Hara I; Muramaki M; Arakawa S; Fujisawa M
Hinyokika Kiyo; 2006 Jul; 52(7):531-6. PubMed ID: 16910585
[TBL] [Abstract][Full Text] [Related]
55. Application of stem cell transplant for brain tumors.
Gardner SL
Pediatr Transplant; 2004 Jun; 8 Suppl 5():28-32. PubMed ID: 15125703
[TBL] [Abstract][Full Text] [Related]
56. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
Zander AR; Kröger N; Schmoor C; Krüger W; Möbus V; Frickhofen N; Metzner B; Schultze W; Berdel WE; Koenigsmann M; Thiel E; Wandt H; Possinger K; Trümper L; Kreienberg R; Carstensen M; Schmidt EH; Jänicke F; Schumacher M; Jonat W
J Clin Oncol; 2004 Jun; 22(12):2273-83. PubMed ID: 15111618
[TBL] [Abstract][Full Text] [Related]
57. Autologous bone marrow transplantation for the treatment of lung cancer.
Lazarus HM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):72-9. PubMed ID: 8211219
[TBL] [Abstract][Full Text] [Related]
58. High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer.
Kotz KW; Schilder RJ
Semin Oncol; 1995 Jun; 22(3):250-62. PubMed ID: 7777869
[No Abstract] [Full Text] [Related]
59. Multiple cycles of high-dose chemotherapy for ovarian cancer.
Schilder RJ; Shea TC
Semin Oncol; 1998 Jun; 25(3):349-55. PubMed ID: 9633847
[TBL] [Abstract][Full Text] [Related]
60. [Place of autologous and allogeneic hematopoietic stem cell transplantation in ovarian cancer].
Nayl B; Cabrespine-Faugeras A; Maliki Y; Bay JO
Bull Cancer; 2009 Dec; 96(12):1225-32. PubMed ID: 19939780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
